产品详情

SB 203580, Hydrochloride,10MG,559395-10MGCN,Sigma

销售价: ¥ 3583.09 / 件
优    惠: 请询价
订货号 0BV3956
品牌型号 559395-10MGCN
货期 询货期
最小订货量 1件
产品介绍 Product Description

General description

A water-soluble form of the potent MAP kinase inhibitor SB 203580 (Cat. No. 559389).


Biochem/physiol Actions

Cell permeable: yes
Primary Target
p38 MAP kinase
Product does not compete with ATP.
Reversible: no
Target IC50: 34 nM against p38 MAP kinase in vitro, 600 nM in cells; 50-100 nM against IL-1 and TNF-a production from LPS-stimulated human monocytes and the human monocyte cell line THP-1; 0.2-1.0 µM against platelet aggregation caused by collagen


Preparation Note

Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.


Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany


Disclaimer

Toxicity: Standard Handling (A)


技术参数 Specifications
Quality Segment100
assay≥95% (HPLC)
formsolid
manufacturer/tradenameCalbiochem®
storage conditionOK to freeze,desiccated (hygroscopic),protect from light
colorbright yellow
solubilitywater: 10 mg/mL,DMSO: soluble
web metadata keyword.default4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-imidazole HCl,SB 203580 HCl stock solution preparation,SB 203580 hydrochloride 100mg for biochemical assays,SB 203580 hydrochloride 869185-85-3,SB 203580 hydrochloride cell permeable inhibitor,SB 203580 hydrochloride for pharmaceutical research,SB 203580 hydrochloride reconstitution guidelines,SB 203580 hydrochloride stability at -20°C,SB 203580 hydrochloride,Sigma-Aldrich SB 203580 hydrochloride 25mg,high-purity SB 203580 hydrochloride,lab-grade SB 203580 hydrochloride for research,p38 MAP Kinase inhibitor SB 203580 hydrochloride
shipped inambient
storage temp.−20°C
SMILES stringFc1ccc(cc1)c2[nH]c(nc2c4ccncc4)c3ccc(cc3)[S](=O)C.Cl
InChI1S/C21H16FN3OS.ClH/c1-27(26)18-8-4-16(5-9-18)21-24-19(14-2-6-17(22)7-3-14)20(25-21)15-10-12-23-13-11-15;/h2-13H,1H3,(H,24,25);1H
InChI keyWOSGGXINSLMASH-UHFFFAOYSA-N
立即咨询